Abstract Body

Background: HIV-infected patients have increased risk for cardiovascular disease (CVD). The underlying mechanism likely involves impaired endothelial function, a precursor of atherosclerosis. Endothelial homeostasis is promoted by the Tie2 receptor system through its agonist, angiopoietin-1 (Ang1) while its antagonist, the inflammatory protein angiopoietin-2 (Ang2), promotes endothelial activation. We hypothesized that HIV infection is associated with decreased Ang1 and increased Ang2 levels, leading to impaired endothelial function.

Methods: We performed a cross-sectional analysis of Ang1 and Ang2 serum levels by ELISA, among 89 HIV-infected individuals, and 46 uninfected controls. Endothelial function was measured by flow-mediated dilation of the brachial artery (FMD). Generalized linear regression models and Spearman correlations were used to determine the association of HIV to Ang1/Ang2 levels and FMD.

Results: The median age was 49 yrs and 87% were male. Compared to controls, HIV-infected individuals were younger (median age 45 yrs vs 53 yrs, p=0.03), less likely to be male (82% vs 98%, p=0.03), and more likely to have renal disease (eGFR<60) (13.5% vs 2.2%, p=0.04). Forty-seven (53%) of the HIV-infected individuals were effectively treated and suppressed with antiretroviral therapy (ART). Compared to controls, Ang1 levels were lower in HIV-infected individuals (median 2219 pg/ml, IQR 1022 to 4280, p= 0.01) while Ang2 levels were higher (median 2147 pg/ml, IQR 1617 to 3106, p=0.06). After adjustment for traditional risk factors, Ang1 levels remained significantly lower in HIV subjects compared to controls (-43.8%, p=0.018) while Ang2 levels were no longer different (p=0.65). Individuals on effective ART had 29% lower Ang1 levels compared to controls in adjusted analysis (p=0.01) and lower Ang1 levels were independently associated with impaired FMD (p<0.001).

Conclusions: Circulating Ang1 levels are reduced among HIV-infected individuals compared to controls, even in subjects on effective ART. Lower Ang1 is independently associated with impaired endothelial function. These data suggest that HIV infection leads to an imbalance between Ang1 and Ang2, resulting in endothelial dysfunction through the Tie2 receptor system. Our findings reveal a potential new target for mitigating CVD risk in the setting of treated HIV infection.